Cryo-Cell International, Inc. (NYSE AMERICAN: CCEL) shared an overview of its financial performance in the first quarter before the market opened, dissecting its most recent financial report for investors.
For the quarter, the company generated revenues of $7.97 million, slightly below the projected $8.04 million.
In the first quarter, the company’s net income per share was $0.03, surpassing the anticipated earnings of $0.02.
The earnings report indicated a 1.5 percent revenue increase compared to the prior year, yet earnings saw a decline of 57.1 percent.